...
首页> 外文期刊>Bioanalysis >Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS.
【24h】

Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS.

机译:通过LC-MS / MS开发大环内酯类免疫抑制剂化合物生物分析方法的挑战。

获取原文
获取原文并翻译 | 示例
           

摘要

The quantification of tacrolimus in human whole blood was developed by LC-MS/MS for a range of 50.0 to 50,000.0 pg/ml. Different challenges were faced during method development due to ion-suppression, lack of sensitivity and low recovery. The optimization of the extraction procedure played a crucial role as tacrolimus had to be isolated from red blood cells, to which it is strongly bound. Another particular challenge arose from the freeze-thaw stability where the extracted samples from fresh blood always showed a lower recovery. Finally, matrix effect was observed in some matrices over time, which resulted in a failed long-term stability in whole blood. In order to resolve the matrix effect issue, the sample procedure had to be improved. The final assay showed good recovery, low matrix effect, linearity, blood stability and good precision and accuracy.
机译:LC-MS / MS建立了人类全血中他克莫司的定量范围为50.0至50,000.0 pg / ml。由于离子抑制,灵敏度低和回收率低,在方法开发过程中面临着不同的挑战。提取程序的优化起着至关重要的作用,因为他克莫司必须从牢固结合的红细胞中分离出来。冻融稳定性带来了另一个特别的挑战,从新鲜血液中提取的样品总是显示出较低的回收率。最后,随着时间的流逝,在某些基质中观察到基质效应,导致全血长期稳定性失败。为了解决基质效应问题,必须改进采样程序。最终测定显示出良好的回收率,低基质效应,线性,血液稳定性以及良好的精密度和准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号